News of the index components SMI

Index

SMI

CH0009980894

Market Closed - Swiss Exchange 18:31:24 09/09/2026 +03 After hours 22:31:30
13,804.70 PTS -1.80% Intraday chart for SMI 13,792.23 -0.09%
03:58pm Berenberg Upbeat on Amrize Amid Positive US Construction Demand MT
03:34pm Intesa Sanpaolo Downgrades Swiss Re to Underperform, Lifts PT MT
03:34pm RBC Capital Markets Kicks Off Novartis Coverage at Sector Perform MT
03:29pm RBC Capital Markets Starts Roche Coverage with Outperform Rating MT
03:28pm AlphaValue/Baader Europe Upgrades Novartis to Add, Trims PT MT
02:02pm Fearless US stock market vulnerable to shocks as midterms loom  RE
01:30pm RBC Initiates Novartis at Sector Perform With CHF120 Price Target MT
12:06pm UBS Doubles Size of Debt Buy-Back Tender Offer to $4 Billion MT
11:42am Nestlé to Invest CHF157 Million on Boosting Pet Food Production in Thailand MT
11:40am Holcim makes an investment in Cloud Cycle Zonebourse
10:47am UBS Group Doubles Debt Tender Offer to $4 Billion MT
10:31am Richemont Names Chairman Johann Rupert's Son as Nonexecutive Co-Deputy Chairman -- Update DJ
10:04am RBC Kicks Off Novartis Coverage at Sector Perform as Pipeline Misses 'Dampened Momentum' MT
09:36am Richemont Names Anton Rupert as Nonexecutive Co-Deputy Chairman DJ
09:18am Richemont appoints Rupert's son Anton co-deputy chairman RE
09:09am Richemont Names Nonexecutive Co-deputy Chairman MT
08:54am RBC Starts Roche Coverage at Outperform on Base Business Improvement, 'Underappreciated' Pipeline MT
08:34am Holcim Invests in UK-based Concrete Management Software Company Cloud Cycle MT
07:53am Swiss stocks - Factors to watch on September 9 RE
09-09 Health Care Down as Novartis, Boston Scientific Weigh - Health Care Roundup DJ
09-08 Logitech Says Shareholders Approve Fiscal 2026 Dividend Increase MT
09-08 Dyne, Sarepta shares tumble as Novartis setback weighs on muscle disease drug developers RE
09-08 Berenberg Upbeat on Holcim Amid Continued Portfolio Evolution; Hold Maintained MT
09-08 Novartis: R&D setbacks are not palatable at premium valuations Alphavalue
09-08 Novartis Sees Avidity Drug Suffer Third Clinical-Trial Setback MT
09-08 ABB Forecasts, Price Objective Revised as BofA Notes Strong Data Center Order Momentum MT
09-08 Monte Rosa to Receive $50 Million Milestone Payment From Novartis for Phase 2 Launch of MRT-6160 MT
09-08 Partners Group Private Equity calls vote on proposals for realisations AN
09-08 BofA Sees Remibrutinib Detailed Data as Next Major Catalyst to Offset Novartis Pipeline Misses; Buy Rating Kept MT
09-08 ABB and Rolls-Royce SMR sign a collaboration agreement for small modular nuclear reactors Zonebourse
09-08 Novartis Stock Tumbles After Late-stage Failure of Myotonic Dystrophy Therapy MT
09-08 Novartis's Latest Trial Setback Sinks Stock DJ
09-08 Novartis Genetic Muscle Disorder Drug Fails Phase 3 Trial; Shares Drop Pre-Bell MT
09-08 Novartis twin drug trial setbacks pile pressure on pipeline, CEO RE
09-08 UBS Group to Redeem GBP750 Million Senior Notes Due 2027 MT
09-08 Novartis reports another clinical setback Zonebourse
09-08 Swiss stablecoin project enters testing phase, adds SIX and TWINT as partners RE
09-08 Novartis announces trial setback on del-desiran drug RE
09-08 Novartis Says Neuromuscular Drug Candidate Misses Goal in Late-Stage Trial DJ
09-08 Novartis Says Delpacibart Etedesiran Missed Primary Endpoint in Late-stage Neuromuscular Disease Study MT
No results match your criteria
  1. Stock Market
  2. Indices
  3. SMI
  4. News SMI
  5. News of the index components
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!